ERYTHROCIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Erythrocin, and what generic alternatives are available?
Erythrocin is a drug marketed by Abbott, Hospira, and Azurity. and is included in five NDAs.
The generic ingredient in ERYTHROCIN is erythromycin stearate. There are one hundred and three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the erythromycin stearate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ERYTHROCIN?
- What are the global sales for ERYTHROCIN?
- What is Average Wholesale Price for ERYTHROCIN?
Summary for ERYTHROCIN
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,113 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ERYTHROCIN |
| DailyMed Link: | ERYTHROCIN at DailyMed |
See drug prices for ERYTHROCIN
Recent Clinical Trials for ERYTHROCIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Janssen Research & Development, LLC | Phase 1 |
Pharmacology for ERYTHROCIN
| Drug Class | Macrolide Antimicrobial Macrolide |
| Physiological Effect | Decreased Sebaceous Gland Activity |
US Patents and Regulatory Information for ERYTHROCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | ERYTHROCIN | erythromycin lactobionate | INJECTABLE;INJECTION | 062586-002 | Jan 4, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | ERYTHROCIN | erythromycin lactobionate | INJECTABLE;INJECTION | 050182-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | ERYTHROCIN | erythromycin lactobionate | INJECTABLE;INJECTION | 050182-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | ERYTHROCIN | erythromycin lactobionate | INJECTABLE;INJECTION | 050609-001 | Sep 24, 1986 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Abbott | ERYTHROCIN | erythromycin lactobionate | INJECTABLE;INJECTION | 062586-001 | Jan 4, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hospira | ERYTHROCIN | erythromycin lactobionate | INJECTABLE;INJECTION | 062638-002 | Oct 31, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
